Resultados a medio-largo plazo de pacientes con diabetes tipo1 remitidos a una consulta monográfica de bombas de insulina

Pickup, 2008, Severe hypoglycaemia and glycaemic control in type 1 diabetes: Meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion, Diabet Med., 25, 765, 10.1111/j.1464-5491.2008.02486.x Jeitler, 2008, Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: Systematic review and meta-analysis, Diabetologia., 51, 941, 10.1007/s00125-008-0974-3 Pickup, 2008, Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes, Diabetes Care., 31, 140S, 10.2337/dc08-s235 Giménez, 2007, Efficacy of continuous subcutaneous insulin infusion in type 1 diabetes: A 2-year perspective using the established criteria for funding from a National Health Service, Diabet. Med., 24, 1419, 10.1111/j.1464-5491.2007.02287.x Causso Lariena, 2009, Análisis de los resultados de la terapia subcutánea continua de insulina como alternativa al tratamiento intensivo en pacientes con diabetes mellitus tipo 1, Av Diabetol., 25, 300 Papargyri, 2014, An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus, Endocrinol Nutr., 61, 141, 10.1016/j.endonu.2013.09.003 Orden por la que se autoriza la financiación de determinados efectos y accesorios con fondos públicos. SCO/710/2004 de 12 de marzo. BOE n.̊ 168, de 19 de marzo de 2004. Linkeschova, 2002, Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy: An observational study of 100 consecutive patients followed for a mean of 2 years, Diabet Med., 19, 746, 10.1046/j.1464-5491.2002.00713.x Retnakaran, 2004, Continuous subcutaneous insulin infusion versus multiple daily injections: The impact of baseline A1c, Diabetes Care., 27, 2590, 10.2337/diacare.27.11.2590 National Institute for Health and Clinical Excellence. Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. Review of technology appraisal guidance 57. Londres: NICE; 2008, Review date: February 2011. [consultado July 2008]. Disponible en: http://guidance.nice.org.uk/TA151/Guidance/pdf/English Grupo de Trabajo de Nuevas Tecnologías de la SED. Guía rápida ISCI. 2007. Sociedad Española de Diabetes (SED) editores. Revisada y actualizada 2012. pp 1-44. Conget, 2013, Posibles causas de la infrautilización de la infusión subcutánea continua de insulina en España, Av Diabetol., 29, 1, 10.1016/j.avdiab.2012.11.002 Carlsson, 2013, Insulin pump-long-term effects on glycemic control: An observational study at 10 diabetes clinics in Sweden, Diabetes Technol Ther., 15, 302, 10.1089/dia.2012.0286 Grant, 2013, The impact of anxiety and depression on patients within a large type 1 diabetes insulin pump population. An observational study, Diabetes Metab., 39, 439, 10.1016/j.diabet.2013.06.003 Pickup, 2014, Insulin pumps, Diabetes Technol Ther., 16, S17, 10.1089/dia.2014.1503 De Vries, 2011, Factors associated with increased risk of insulin pump discontinuation in pediatric patients with type 1 diabetes, Pediatr Diabetes., 12, 506, 10.1111/j.1399-5448.2010.00701.x Hofer, 2010, Discontinuation of insulin pump treatment in children, adolescents, and young adults. A multicenter analysis based on the DPV database in Germany and Austria, Pediatr Diabetes., 11, 116, 10.1111/j.1399-5448.2009.00546.x Lombardo, 2012, Failure of glycated hemoglobin drop after continuous subcutaneous insulin infusion initiation may indicate patients who discontinue: A 4-year follow-up study in children and adolescents with type 1 diabetes, Acta Diabetol., 49, S99, 10.1007/s00592-011-0344-3